Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $47.9700 (-3.6%) ($47.9700 - $47.9700) on Mon. Mar. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 58 | Latest Price | $47.9700(-3.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 2.6% a day on average for past five trading days. | Weekly Trend | TGTX advances 4.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(64%) ARKK(59%) IBB(59%) IWO(59%) | Factors Impacting TGTX price | TGTX will decline at least -1.645% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-19%) UNG(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | -2.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $48.02(-0.1%) | 10 Day Moving Average | $45.59(5.22%) | 20 Day Moving Average | $45.41(5.64%) | To recent high | -12.4% | To recent low | 15.1% | Market Cap | $6.075b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |